...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: TD Zenith Capital Corp | Grey Market : ZHCLF
Reply New Message
Prev Message Back To Forum Threaded View Next Message

You are responding to a July message. Since then, I called them.  Other folks have called them.  And it appears they looked into it because they disconnected it from ZHCLF a couple months ago.

1 Recommendations
Reply New Message
Prev Message Back To Forum Threaded View Next Message
Share
Share
New Message
Please login to post a reply